0001217234-20-000059.txt : 20200507
0001217234-20-000059.hdr.sgml : 20200507
20200507192919
ACCESSION NUMBER: 0001217234-20-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200506
FILED AS OF DATE: 20200507
DATE AS OF CHANGE: 20200507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAGSTROM WILLIAM A
CENTRAL INDEX KEY: 0001042875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 20858239
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_158889414197989.xml
FORM 4
X0306
4
2020-05-06
0
0001217234
CareDx, Inc.
CDNA
0001042875
HAGSTROM WILLIAM A
C/O CAREDX, INC.
1 TOWER PLACE, 9TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2020-05-06
4
M
0
15000
1.22
A
30385
D
Common Stock
2020-05-06
4
S
0
15000
29.1219
D
15385
D
Stock Option (right to buy)
1.22
2020-05-06
4
M
0
15000
1.22
D
2027-07-13
Common Stock
15000.0
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.77 to $29.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
1/12th of the shares subject to the option vested on August 13, 2017 and 1/12th of the shares subject to the option vested monthly thereafter through July 13, 2018.
/s/ Peter Maag as attorney-in-fact for William A. Hagstrom
2020-05-07